Skip to main content
. Author manuscript; available in PMC: 2009 Jan 14.
Published in final edited form as: Eur J Pharmacol. 2007 Oct 2;578(2-3):349–358. doi: 10.1016/j.ejphar.2007.09.029

TABLE 1.

Affinity values, and percentage and subcellular location of binding sites for α1-adrenoceptor drugs in submandibular gland acinar cells (SMG-C10).

A

Drug Ki (nM) nH KiH (nM) % High KiL (nM) % Low n
Prazosin 0.33 ± 0.1 −0.75 ± 0.1 4
BMY 7378 122 ± 27 −0.87 ± 0.2 4
5-methylurapidila −0.58 ± 0.1 0.64 ± 0.3 21 ± 4 91 ± 7 79 ± 5 5

B

% [3H]Prazosin Binding 19 ± 2 71 ± 3
Sucrose Density Gradient Fraction Number 3 – 5b 9 – 10c

A. The values are mean ± S.E.M.; n, number of separate SMG-C10 cell cultures. Ki, is affinity in nM of drugs for inhibiting specific [125I]HEAT binding; nH, Hill coefficient. Affinity values from binding data that fit best to a two-site binding model are expressed as KiH (high-affinity binding site) and KiL (low-affinity binding site). % High, percentage of high-affinity binding sites; % Low, percentage of low affinity binding sites. B. % [3H]Prazosin Binding, percentage of specific [3H]prazosin binding sites in subcellular fractions separated by sucrose density gradient centrifugation. Values are mean ± S.E.M. of five experiments using separate SMG-C10 cell cultures.

a

Competition binding curves fit best by nonlinear least-squares curve-fitting regression to a two-site binding model (p < 0.05) using the F test.

b

Fractions containing intracellular vesicles.

c

Fractions containing plasma membranes.